The changing landscape of psoriasis - 21/08/11
Jennifer Cather, MD, Alan Menter, MD, Mary Waitrowski, RN, Melody Young, MSN, Texas Dermatology Associates, Dallas, TX, United States
Le texte complet de cet article est disponible en PDF. P2799 Dr. Cather has received research support and/or is a consultant and/or lecturer for : Abbott Laboratories, Allergan, Inc., Amgen, Inc., Astralis, Inc., Berlex, Inc., Biogen Idec, Bradley Pharmaceuticals, Brymill Cryogenics, Centocor, Inc., Collagenex Pharmaceuticals, Connetics Corporation, Corixa Corporation, Dermik Laboratories, Doak Dermatologics, Ferndale Laboratories, Inc., Fujisawa Healthcare, Inc., Galderma, Genentech, Inc., GlaxoSmithKline, IDEC Corporation, Inamed Corporation, Ligand Pharmaceuticals, Medicis, MedImmune, Inc., Novartis Pharmaceuticals, Otsuka Pharmaceutical, Inc., Protein Design Labs, Serono, Synta Pharma, and 3M Pharmaceuticals. |
Vol 52 - N° 3S
P. P196 - mars 2005 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?